| Schedule of components of net gain on securities |
This item consists of the following:
|
|
|
|
|
|
|
|
|
|
|
2019
|
|
2018
|
|
2017
|
|
|
|
S/(000)
|
|
S/(000)
|
|
S/(000)
|
|
|
|
|
|
|
|
|
|
Net gain on the purchase and sale of securities
|
|
317,862
|
|
135,253
|
|
658,495
|
|
Net gain in associates (*)
|
|
79,844
|
|
72,254
|
|
49,268
|
|
Net gain on financial assets at fair value through profit or loss
|
|
147,582
|
|
33,333
|
|
54,019
|
|
Recovery of credit loss for investments at fair value through other comprehensive income, Note 6(b)
|
|
745
|
|
1,909
|
|
—
|
|
Credit loss on investments available-for-sale
|
|
—
|
|
—
|
|
(766)
|
|
Others
|
|
781
|
|
80
|
|
(244)
|
|
Total
|
|
546,814
|
|
242,829
|
|
760,772
|
(*)It mainly includes the gain of its associated “Entidad Prestadora de Salud” for approximately S/53.6 million during the year 2019 (S/50.4 million during the year 2018).
|